| 11529363 |
Methods of treating cancer in pediatric patients |
Sharon Bowen, David Kerstein, Karthik Venkatakrishnan |
2022-12-20 |
|
| 9453063 |
Hybrid polypeptides with selectable properties |
Odile Esther Levy, Carolyn M. Jodka, Diana Y. Lewis, Christopher J. Soares, Soumitra S. Ghosh +3 more |
2016-09-27 |
|
| 9133260 |
GIP analog and hybrid polypeptides with selectable properties |
Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +9 more |
2015-09-15 |
|
| 8895498 |
GIP and exendin hybrid polypeptides |
Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra G. Ghosh +10 more |
2014-11-25 |
$25,833,000 |
| 8697647 |
Hybrid polypeptides with selectable properties |
Odile Esther Levy, Carolyn M. Jodka, Diana Y. Lewis, Christopher J. Soares, Soumitra S. Ghosh +3 more |
2014-04-15 |
|
| 8598120 |
Methods for treatment using amylin family peptides |
Christopher J. Soares, Diana Y. Lewis, David G. Parkes, Carolyn M. Jodka, Kathryn S. Prickett +3 more |
2013-12-03 |
$12,087,000 |
| 8497240 |
DPP-IV resistant GIP hybrid polypeptides with selectable properties |
Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +10 more |
2013-07-30 |
$20,571,000 |
| 8404637 |
GIP analog and hybrid polypeptides with selectable properties |
Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +9 more |
2013-03-26 |
|
| 8389477 |
Amylin and amylin agonists for treating psychiatric diseases and disorders |
Kevin D. Laugero, Christine M. Mack, David G. Parkes, Andrew A. Young |
2013-03-05 |
$3,955,000 |
| 8309522 |
Neuromedin and FN-38 peptides for treating psychiatric diseases |
Kevin D. Laugero, Christine M. Mack, David G. Parkes, Paul McGonigle |
2012-11-13 |
|
| 8263545 |
GIP analog and hybrid polypeptides with selectable properties |
Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +10 more |
2012-09-11 |
|
| 8114958 |
Amylin family peptides |
Christopher J. Soares, Diana Y. Lewis, David G. Parkes, Carolyn M. Jodka, Kathryn S. Prickett +3 more |
2012-02-14 |
$35,489,000 |
| 8076288 |
Hybrid polypeptides having glucose lowering activity |
Odile Esther Levy, Carolyn M. Jodka, Diana Y. Lewis, Christopher J. Soares, Soumitra S. Ghosh +3 more |
2011-12-13 |
$18,491,000 |
| 7671023 |
Amylin agonist for treating depression, anxiety disorder and schizophrenia |
Kevin D. Laugero, Christine M. Mack, David G. Parkes, Andrew A. Young |
2010-03-02 |
$29,792,000 |
| 7595341 |
Analogues of lipid mediators derived from ω-3 PUFAs and methods of use |
Daniel W. Goodman, Stuart L. Bursten, Charles N. Serhan |
2009-09-29 |
|
| 7378444 |
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use |
Daniel W. Goodman, Stuart L. Bursten, Charles N. Serhan |
2008-05-27 |
|
| RE39849 |
Methods for identifying modulators of CCX CKR activity |
Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Thomas Schall |
2007-09-18 |
|
| 7108990 |
Chemokine receptor |
Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Thomas Schall |
2006-09-19 |
|
| 6998239 |
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine |
Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Dale Talbot, Thomas Schall |
2006-02-14 |
|
| 6835547 |
Methods for identifying modulators of CCX CKR activity |
Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Dale Talbot, Thomas Schall |
2004-12-28 |
|